Activity: Immobilized Human GPC3 VLP at 5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA.
Recombinant Human GPC3 VLP is expressed from E.coli.It contains Gly510-Asn554.
Product Background
Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed.
Product Category
Recombinant Protein
/
Antibody discovery, Cell therapy
/
ADC targets
Immobilized Human GPC3 VLP at 5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA.
Expression System
E.coli
Endotoxin
Less than 1 EU per ug by the LAL method.
Shipping, Reconstitution, & Storage
Form
Liquid
Shipping
Shipped with dry ice.
Formulation
Supplied as 0.22um filtered solution in 20mM HEPES, 500mM NaCl, 10% Glycerol, 0.1% Tween20 (pH 7.7).
Stability And Storage
Valid for 12 months from date of receipt when stored at -80°C.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Validation Images
Immobilized Human GPC3 VLP at 5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA.